Pharmacological disease models
Small molecules and excitotoxic agents can be used to pharmacologically induce disease models such as epilepsy, Parkinson's Disease, catalepsy, Schizophrenia, pain and diabetes models. Researchers can save up to 50% on excitotoxic agents - they are up to half the price of other suppliers.
Show/Hide Filters
- Description:
Selective α-mannosidase I inhibitor
2,4-Diamino-6-hydroxypyrimidine (HB0070)
Description:GTP cyclohydrolase I (GCH1) inhibitor
Purity:>98%
5,7-Dichlorokynurenic acid (HB0078)
Description:Potent, selective, competitive glycine site NMDA receptor antagonist
Purity:>98%
Dihydrochlamydocin (HB3874)
Description:Phytotoxin. Derivative of the HDAC inhibitor chlamydocin.
Purity:>95%
Dihydroergocristine mesylate (HB1611)
Description:5-HT antagonist. Also partial agonist at adrenergic and dopaminergic receptors.
Purity:>98%
Dihydroergotamine mesylate (HB1612)
Description:Partial α-adrenergic agonist, partial D2 agonist and 5-HT antagonist
Purity:>98%